InflaRx (IFRX) Interest Expenses (2016 - 2026)

InflaRx has disclosed Interest Expenses across 11 years of filings, most recently posting -$17337.6 for Q1 2026.

• Interest Expenses for Q1 2026 came in at -$17337.6, down 303.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $33130.3 (up 67.25% YoY), and the FY2025 annual result was $45675.9, up 106.94% from the prior year.
• Interest Expenses came in at -$17337.6 for Q1 2026 at InflaRx, down from $71052.1 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $71052.1 in Q4 2025 to a low of -$6.9 billion in Q3 2022.
• The 5-year median for Interest Expenses is -$5526.2 (2024), against an average of -$755.0 million.
• Across the five-year window, Interest Expenses slumped 61429313.35% in 2022 and soared 1017.49% in 2023, its largest moves.
• InflaRx's Interest Expenses stood at -$5992.9 in 2022, then soared by 1017.49% to $54984.8 in 2023, then retreated by 29.0% to $39036.9 in 2024, then surged by 82.01% to $71052.1 in 2025, then sank by 124.4% to -$17337.6 in 2026.
• The last three Interest Expenses figures came in at -$17337.6 (Q1 2026), $71052.1 (Q4 2025), and -$16786.5 (Q3 2025), per Business Quant data.